Processes Involved in the Site-Specific Effect of Probucol on Atherosclerosis in Apolipoprotein E Gene Knockout Mice
- 1 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (8) , 1684-1690
- https://doi.org/10.1161/01.atv.0000174125.89058.b6
Abstract
Objective— To elucidate processes by which the antioxidant probucol increases lesion size at the aortic sinus and decreases atherosclerosis at more distal sites in apolipoprotein E–deficient (apoE−/−) mice. Methods and Results— Male apoE−/− mice were fed high-fat chow with 1% (w/w) probucol or without (controls) for 6 months, before aortic sinus, arch, and descending aorta were analyzed separately for lesion size and composition. Compared with control, probucol significantly increased lesion size by 33% at the sinus, but it inhibited atherosclerosis at the descending aorta by 94%. Sites where atherosclerosis was inhibited contained substantially fewer macrophages, less lipids (cholesterol and cholesteryl esters), and endogenous antioxidant (α-tocopherol), but not oxidized lipids, and the extent to which probucol metabolism occurred was increased. Compared with control, aortic sinus lesions of probucol mice contained a substantially increased content of extracellular matrix, but decreased total cell and macrophage density, comparable levels of lipids and α-tocopherol, and decreased concentrations of oxidized lipids (cholesteryl ester hydroperoxides, F2-isoprostanes, and 7-ketocholesterol). Conclusions— Probucol affects atherosclerosis in apoE−/− mice independent of the accumulation of arterial lipid oxidation products, thereby dissociating the 2 processes. Rather, probucol exerts antiinflammatory activity by decreasing accumulation of macrophages in lesions, and it promotes a more stable lesion composition at the aortic sinus. We investigated how the antioxidant probucol increases lesion size at the sinus and decreases atherosclerosis at distal sites in apolipoprotein E-deficient mice. Probucol affected atherosclerosis independent of arterial lipid oxidation. Rather, probucol decreased accumulation of macrophages in lesions, and it promoted a more stable lesion composition at the aortic sinus.Keywords
This publication has 29 references indexed in Scilit:
- Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 2004
- Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1Circulation, 2004
- Probucol Promotes Functional Reendothelialization in Balloon-Injured Rabbit AortasCirculation, 2003
- Effects of AGI-1067 and Probucol After Percutaneous Coronary InterventionsCirculation, 2003
- Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Disease Stage-Dependent Accumulation of Lipid and Protein Oxidation Products in Human AtherosclerosisThe American Journal of Pathology, 2002
- Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbitsJournal of Clinical Investigation, 1999
- Oxidation and Antioxidation of Human Low-Density Lipoprotein and Plasma Exposed to 3-Morpholinosydnonimine and Reagent PeroxynitriteChemical Research in Toxicology, 1998
- Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.Journal of Clinical Investigation, 1997
- Beyond CholesterolNew England Journal of Medicine, 1989